Becker’s Payer Issues Podcast Rethinking GLP 1 Coverage Through Transparent, Consumer First Pharmacy Models
6 snips
Jan 23, 2026 
Bethanie Stein, Segment President of Pharmacy at Humana and a trained pharmacist, shares her insights on GLP-1 coverage evolution. She highlights how employers are shifting to responsible, transparent coverage strategies. The discussion emphasizes CenterWell Pharmacy's consumer-first model focusing on transparency and clinical outcomes. Stein also addresses collaborations with manufacturers like Eli Lilly and Novo Nordisk to reduce costs and improve access. Lastly, she advocates for robust adherence programs that lead to better health outcomes and fewer hospital visits.
AI Snips
Chapters
Transcript
Episode notes
Employers Seek Intentional GLP‑1 Benefit Design
- Employers want predictability, control, and transparency when covering GLP-1s rather than blanket coverage decisions.
- Segmenting populations by clinical need and treatment phase helps balance access with financial sustainability.
Direct Pharmacy Models Can Bend The Cost Curve
- A transparent, direct-to-pharmacy model can lower out-of-pocket costs and reduce waste in the supply chain.
- Simplifying access while enforcing clinical oversight helps expand safe, affordable GLP-1 access at scale.
CenterWell Built Around Outcomes And Transparency
- CenterWell was built by Humana for the health plan to prioritize outcomes, transparency, and affordability over spread pricing.
- The model drove 15% fewer ER visits and 13% lower hospitalizations versus other pharmacies in their network.